Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Should we continue using amphotericin B deoxycholate for the treatment of fungal infections?

April 26, 2017amphotericin Continue deoxycholate fungal infections treatment

0

Posted

Should we continue using amphotericin B deoxycholate for the treatment of fungal infections?

1 Answer

0

Posted

Amphotericin B deoxycholate (AmBd) has been a standard therapy for IFI but is associated with high adverse event and mortality rates. A retrospective review was undertaken to describe adverse events and clinical outcomes in adult patients with IFI treated with only AmBd as initial therapy.